Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 13;15:8945–8961. doi: 10.2147/IJN.S269982

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Cao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The inflammatory cell counts in BALF and lung histologic changes in the six groups (n = 6). (A) The inflammatory cell counts in BALF of each group. ILQ-SMEDDS treatment apparently decreased the inflammatory cell counts in BALF of OVA-induced asthma model. The data shown are the mean ± SD. * p < 0.05, **p < 0.01. (B and C) Lungs from the indicated mice sectioned and stained with Hematoxylin-Eosin stain ((B) H&E, ×400) and Periodic Acid-Schiff stain ((C) PAS, ×400). (i: Naïve group, PBS treatment; ii: Sham group, OVA i.p. and i.t. iii: Dex-treated mice (0.5 mg/kg) with OVA i.p. and i.t. iv: ILQ-treated mice (10 mg/kg) with OVA i.p. and i.t. v, vi: ILQ-SMEDDS-treated mice (10, 20 mg/kg) with OVA i.p. and i.t.).